使用FRED血流导向装置治疗破裂血泡样动脉瘤的多中心经验
这项回顾性多中心研究分析了2013年1月至2019年5月间30例接受FRED血流导向装置治疗的破裂颅内血泡样动脉瘤患者,评估其安全性和有效性。结果显示6个月时80%随访患者达到完全闭塞,最终随访(中位22个月)达92%,无再出血;77%患者6个月mRS 0-2,主要卒中或死亡发生率为17%,作者认为FRED治疗破裂血泡样动脉瘤安全有效。
要点
- FRED治疗破裂血泡样动脉瘤的6个月完全闭塞率为80%,最终随访达92%。
- 6个月mRS 0-2的患者占77%,主要卒中或死亡发生率为17%,无再出血。
- 本组中2例死于肺炎,2例死于脑血管痉挛后梗死,1例迟发性无症状支架闭塞。
核心结论
- 作者结论认为,使用FRED治疗破裂血泡样动脉瘤是安全有效的。
研究设计与样本
- 回顾性多中心研究,纳入了2013年1月至2019年5月间所有因破裂颅内血泡样动脉瘤接受FRED治疗的患者,共30例患者30个动脉瘤;主要疗效终点为治疗后无再出血及6个月随访时按O'Kelly-Marotta分级达到完全血管造影闭塞。
关键影像表现/征象
- 术后即刻完全闭塞(O'Kelly-Marotta分级D)在10例患者中实现(33%)。
- 26例有随访的患者中,6个月随访时21例(80%)达到完全闭塞,最终随访(中位22个月)时24例(92%)达到完全闭塞。
- 发生迟发性无症状支架闭塞1例。
诊断标准与关键数值
- 完全闭塞依据O'Kelly-Marotta分级,术后即刻完全闭塞(D级)10例(33%)。
- 6个月随访完全闭塞21/26例(80%);最终随访(中位22个月)完全闭塞24/26例(92%)。
- 临床安全终点:6个月mRS 0-2的患者23/30例(77%);主要同侧卒中或死亡发生率为17%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Treatment of ruptured blister-like aneurysms is technically challenging. This study aimed at analyzing the safety and efficacy of the Flow-Redirection Endoluminal Device (FRED) in the treatment of ruptured blister-like aneurysms.
MATERIALS AND METHODS: In a retrospective multicenter study, all patients treated with the FRED due to a ruptured intracranial blister-like aneurysm between January 2013 and May 2019 were analyzed. The primary end points for clinical safety were mRS 0-2 at 6 months after treatment and the absence of major ipsilateral stroke or death. The primary end points for efficacy were the absence of rebleeding after treatment and complete angiographic occlusion according to the O'Kelly-Marotta classification at 6 months after treatment.
RESULTS: In total, 30 patients with 30 ruptured blister-like aneurysms were treated. Immediate complete aneurysm obliteration (O'Kelly-Marotta classification D) with the FRED was achieved in 10 patients (33%). Of the 26 patients with follow-up, complete obliteration was achieved in 21 patients (80%) after 6 months and in 24 patients (92%) in the final follow-up (median, 22 months). Twenty-three patients (77%) achieved mRS 0-2 at 6 months. Major stroke or death occurred in 17%. Two patients died due to pneumonia, and 2 patients died due to infarction following cerebral vasospasm. There was no case of rebleeding after FRED implantation. There was 1 case of delayed asymptomatic stent occlusion.
CONCLUSIONS: Treatment of ruptured blister-like aneurysms with the FRED is safe and effective.
引用
- Möhlenbruch MA, Seker F, Özlük E, et al. Treatment of Ruptured Blister-Like Aneurysms with the FRED Flow Diverter: A Multicenter Experience. AJNR Am J Neuroradiol. 2020. PMID: 33122212. doi:10.3174/ajnr.A6849
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。